A study suggests a novel role for NSD2 in the immune infiltration of prostate cancer, with elevated levels of the WHSC1 enzyme limiting lymphocyte infiltration in prostate cancer tumours, and positively correlating with the presence of an immunosuppressive microenvironment14. This evidence concerns the gene NSD2 and prostate cancer.